Evaluation of adenosine efficacy in the treatment of ventricular tachycardia
Phase 3
Completed
- Conditions
- Paroxysmal Supraventricular tachycardia.Abnormalities of heart beat
- Registration Number
- IRCT20190929044919N1
- Lead Sponsor
- Alborz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 142
Inclusion Criteria
The patient should have informed consent to participate in the study
The patient has a Paroxysmal Supraventricular Tachycardia
The patient's age is in the range of 70-18 years
Exclusion Criteria
The Patient dissatisfaction to participate in the intervention
Patient sensitivity to adenosine
The patient has first and second degree AV node blocks
The patient has sick sinus syndrome
The patient has a history of previous seizures and epilepsy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Heart rhythm. Timepoint: After injecting the final dose of adenosine. Method of measurement: ECG.
- Secondary Outcome Measures
Name Time Method